《大行報告》瑞銀下調友邦(01299.HK)目標價至110元 評級「買入」
瑞銀發表報告指,友邦保險(01299.HK)將於下周五(12日)公布今年第三季業績,預期集團季度新業務價值以固定匯率計增長4%(撇除約2%的正面匯率影響),由於地區大多數市場受惠於去年第三季的解除封鎖,因此基數較高。
該行又預期,友邦中國第三季的增長將較上半年溫和,主因疫情封鎖等,但仍然較其內地同業更有韌性。而中港開關繼續為潛在正面催化劑,目前該行假設集團的香港離岸銷售會於明年中開始復甦。
瑞銀下調友邦股份目標價,由115元降至110元,評級維持「買入」,並調低集團今年至2023年的新業務價值增長預測5%至6%,至介乎19%至26%,以反映內地保險行業面對的挑戰。至於明年及2023年每股盈利預測亦各調低1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.